Ixazomib-Lenalidomide-Dexamethasone (IRd) Combination before and after Autologous Stem Cell Transplantation (ASCT) Followed By Ixazomib Maintenance Is a Safe and Effective Strategy in Patients with Newly Diagnosed Multiple Myeloma (NDMM): A Phase 2 Study from the Intergroupe Francophone Du MyéLome (
暂无分享,去创建一个
P. Moreau | H. Avet-Loiseau | X. Leleu | L. Planche | C. Touzeau | G. Marit | T. Facon | B. Arnulf | T. Dejoie | M. Attal | L. Garderet | M. Roussel | L. Karlin | A. Perrot | M. Tiab | L. Benboubker | C. Hulin | D. Caillot